Over the past decade, as the majority of patients with single ventricle anatomy who have
undergone the Fontan operation reach adulthood, a newly recognized disease process …

Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

Combined heart–liver transplantation is a rare, life-saving procedure that treats complex and
often fatal diseases including familial amyloidosis polyneuropathy and late stage congenital …

When transplanted simultaneously, the liver allograft has been thought to have an
immunoprotective role on other organs; however, detailed analyses in simultaneous heart …

BACKGROUND Indications for a heart‒liver transplantation (HLT) for Fontan recipients are
not well defined. We compared listing characteristics, post-operative complications, and post …

Background Heart transplant has become the gold standard therapy for end-stage heart
failure. Short-and long-term outcomes after orthotopic heart transplant have been excellent …

Background/methods The aging patient with severe congenital heart disease (CHD) faces
many challenges: heart failure, arrhythmia, and in the Fontan patient, liver disease. Our goal …

Background Cardiac amyloidosis, typically from abnormal deposition of AL or ATTR amyloid
protein, can result in heart failure requiring transplantation (HTx). The role of mechanical …

Opinion statement Adults with complex congenital heart disease that resulted in a Fontan
procedure frequently experience late cardiac failure. Increasingly, liver disease is …

Although heart transplantation is the preferred therapy for appropriate patients with
advanced heart failure, the presence of concomitant renal or hepatic dysfunction can pose a …